Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1649, 2008-01, pp. : 13-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Raltegravir sets new BENCHMRK in treatment-resistant HIV
Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. :
Access to resources
Recommend
Raltegravir rewards reinforced in ART-naive HIV-1 infections
Inpharma, Vol. 1, Iss. 1651, 2008-01 ,pp. :
Raltegravir: an integrase inhibitor for HIV-1
By Evering Teresa H Markowitz Martin
Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. :
Raltegravir to the rescue for treatment-naive patients with HIV-1
Inpharma, Vol. 1, Iss. 1652, 2008-01 ,pp. :
Raltegravir: a guide to its use in HIV-1 infection
Drugs & Therapy Perspectives, Vol. 24, Iss. 6, 2008-06 ,pp. :